Arkolith/Insider Trading/VIRX/Form 4

Chevallard Daniel R.

CFO and COOViracta Therapeutics, Inc. (VIRX) · full profile →Form 4 · filed May 26, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 25, 2023Option exercise(M)7K—$096K
May 25, 2023Sell(S)4K$1.42$5K92K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 25, 2023Option exercise(M)7K—$055K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-032707) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML